» Authors » Olaf M Dekkers

Olaf M Dekkers

Explore the profile of Olaf M Dekkers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 315
Citations 8148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Groenwold R, le Cessie S, Dekkers O
Eur J Endocrinol . 2025 Mar; PMID: 40080665
Although many papers of medical research report on a treatment effect, it is not always clear what is exactly meant by that effect. An estimand is a precise definition of...
2.
Papazisi O, van der Schoot M, Berendsen R, Arbous S, le Cessie S, Dekkers O, et al.
J Cardiothorac Vasc Anesth . 2025 Mar; PMID: 40074583
Objectives: To identify differences in the reported vasoplegia incidence, intensive care unit (ICU) length of stay (LOS), and 30-day mortality rates as influenced by different vasoplegia definitions used in cardiac...
3.
Isand K, Arima H, Bertherat J, Dekkers O, Feelders R, Fleseriu M, et al.
Eur J Endocrinol . 2025 Feb; 192(3):R17-R27. PMID: 39973025
The objective of this study was to establish recommendations for thromboprophylaxis in patients with endogenous Cushing's syndrome (CS), addressing the elevated risk of venous thromboembolism (VTE) associated with hypercortisolism. A...
4.
Ter Haar S, van Goor S, Corssmit E, van Erkel A, Ballieux B, Dekkers O, et al.
Front Endocrinol (Lausanne) . 2025 Feb; 15:1497787. PMID: 39897961
Objective: Primary aldosteronism (PA) is a common cause of secondary hypertension with unilateral and bilateral subtypes requiring different treatments. Adrenal vein sampling (AVS) is the gold standard for subtype differentiation...
5.
Laugesen K, Dekkers O, Groenwold R, Groenwold R, Skajaa N
Eur J Endocrinol . 2025 Feb; 192(2):E1-E3. PMID: 39891549
Selection in clinical research does not necessarily result in selection bias. To understand when selection leads to bias, we discuss collider-conditioning bias, which is a common and often self-inflicted type...
6.
Caram-Deelder C, van Hylckama Vlieg A, Groenwold R, Chen Q, Mook-Kanamori D, Dekkers O, et al.
IJID Reg . 2025 Jan; 14():100500. PMID: 39830316
Objectives: The overall impact of the COVID-19 pandemic on mortality can be estimated by the assessment of excess deaths from all causes because the reported number of deaths due to...
7.
Jansen M, Dekkers O, le Cessie S, Hooft L, Gardarsdottir H, de Boer A, et al.
Pharmacoepidemiol Drug Saf . 2025 Jan; 34(1):e70074. PMID: 39777765
Purpose: Real-world evidence (RWE) is increasingly considered in regulatory and health technology assessment (HTA) decision-making, though perspectives on its relevance may vary. Expanding on a recent review regarding regulatory decisions,...
8.
Fustolo-Gunnink S, de Boode W, Dekkers O, Greisen G, Lopriore E, Russo F
Pediatr Res . 2024 Nov; PMID: 39609614
Complexity science is a discipline which explores how complex systems behave and how we interact with them. Though it is widely implemented outside medicine, particularly in the sciences involving human...
9.
Arbous S, Termorshuizen F, Brinkman S, de Lange D, Bosman R, Dekkers O, et al.
Crit Care . 2024 Nov; 28(1):374. PMID: 39563453
Background: Sepsis is a frequent reason for ICU admission and a leading cause of death. Its incidence has been increasing over the past decades. While hospital mortality is decreasing, it...
10.
Jansen M, Groenwold R, Dekkers O
Eur J Endocrinol . 2024 Oct; 191(5):E5-E9. PMID: 39471402
Researchers frequently come across sample size calculations in the scientific literature they read, in projects undertaken by their peers, and likely within their own work. However, despite its ubiquity, calculating...